Selumetinib
Drug timelines are a Plus or Pro feature.
67 regulatory and trial events tracked for Selumetinib, covering 2012-09-06 to 2026-07-28. Get the full timeline:
Most recent: Clinical Trial Results: Durvalumab, Tremelimumab, and Selumetinib in Treating Participants With Recurrent or Stage IV Non-small Cell Lung Cancer [Phase 1, Phase 2]